Jung Alesia M, Missmer Stacey A, Cramer Daniel W, Ginsburg Elizabeth S, Terry Kathryn L, Vitonis Allison F, Farland Leslie V
Mel and Enid Zuckerman College of Public Health, University of Arizona, 1295 N. Martin Avenue, Tucson, AZ, 85724, USA.
Department of Obstetrics, Gynecology, and Reproductive Biology, College of Human Medicine, Michigan State University, East Lansing, MI, USA.
Fertil Res Pract. 2021 Mar 12;7(1):7. doi: 10.1186/s40738-021-00099-2.
Infertility history may have important implications for clinical practice and scientific discovery. Previous research on the validity of self-reported infertility measurements has been limited in scope and duration (< 5 years). In this study, we validated self-reported infertility history measures 15-23 years after fertility treatment initiation among women who utilized assisted reproductive technology (ART).
Women who received ART treatments from three Boston infertility clinics and who enrolled in a prior study (1994-2003) were re-contacted in 2018 for the AfteR Treatment Follow-up Study (ART-FS). Infertility history was collected from clinical records and two self-report questionnaires (at ART initiation and at ART-FS enrollment). Treatment history included specific details (fresh or frozen embryo transfers, number of cycles) and treatment recall prior to ART initiation. Self-reported infertility diagnoses included polycystic ovary syndrome (PCOS), endometriosis, uterine factor infertility, tubal factor infertility, diminished ovarian reserve/advanced maternal age, male factor infertility, and other/unknown. We compared self-reported measures from 2018 to self-reported and clinical data from prior study initiation, using Cohen's kappa, sensitivity, specificity, and 95% confidence intervals.
Of 2644 women we attempted to recontact, 808 completed the ART-FS, with an average follow-up of 19.6 years (standard deviation: 2.7). Recall of fertility treatment usage had moderate sensitivity (IVF = 0.85, Clomiphene/Gonadotropin = 0.81) but low specificity across different infertility treatment modalities (IVF = 0.63, Clomiphene/Gonadotropin = 0.55). Specific IVF details had low to moderate validity and reliability with clinical records. Reliability of recalled infertility diagnosis was higher when compared to self-report at ART initiation (PCOS K = 0.66, Endometriosis K = 0.76, Tubal K = 0.73) than when compared to clinical records (PCOS K = 0.31, Endometriosis K = 0.48, Tubal K = 0.62) and varied by diagnosis.
The ability of women to recall specific IVF treatment details was moderately accurate and recall of self-reported infertility diagnosis varied by diagnosis and measurement method.
不孕史可能对临床实践和科学发现具有重要意义。先前关于自我报告的不孕测量有效性的研究在范围和持续时间上有限(<5年)。在本研究中,我们在接受辅助生殖技术(ART)的女性开始生育治疗15 - 23年后,验证了自我报告的不孕史测量方法。
从三家波士顿不孕诊所接受ART治疗且参与过先前一项研究(1994 - 2003年)的女性,于2018年被重新联系以参与治疗后随访研究(ART - FS)。不孕史通过临床记录和两份自我报告问卷收集(在开始ART时和在ART - FS入组时)。治疗史包括具体细节(新鲜或冷冻胚胎移植、周期数)以及开始ART治疗前的治疗回忆。自我报告的不孕诊断包括多囊卵巢综合征(PCOS)、子宫内膜异位症、子宫因素不孕、输卵管因素不孕、卵巢储备功能减退/高龄产妇、男性因素不孕以及其他/不明原因。我们使用科恩kappa系数、敏感性、特异性和95%置信区间,将2018年的自我报告测量结果与先前研究开始时的自我报告和临床数据进行比较。
在我们试图重新联系的2644名女性中,808名完成了ART - FS,平均随访时间为19.6年(标准差:2.7)。对生育治疗使用情况的回忆具有中等敏感性(体外受精[IVF]=0.85,克罗米芬/促性腺激素=0.81),但在不同不孕治疗方式中特异性较低(IVF = 0.63,克罗米芬/促性腺激素 = 0.55)。特定IVF细节与临床记录相比,有效性和可靠性低至中等。与开始ART时的自我报告相比(PCOS的kappa系数K = 0.66,子宫内膜异位症的K = 0.76,输卵管因素的K = 0.73),回忆的不孕诊断可靠性高于与临床记录相比(PCOS的K = 0.31,子宫内膜异位症的K = 0.48,输卵管因素的K = 0.62),且因诊断而异。
女性回忆特定IVF治疗细节的能力中等准确,自我报告的不孕诊断回忆因诊断和测量方法而异。